Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-23

Clinical Trial Update: Efficacy and Safety of Mycophenolate Mofetil in subjectswithSjogren's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the efficacy and safety of mycophenolate mofetil in Sjögren's syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Kaohsiung Medical University | Conditions: Sjogren's Syndrome | Phase 2 | Status: UNKNOWN